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AbsTrACT
Aims To evaluate on optical coherence tomography 
angiography (OCT-A), the predictive role of different 
qualitative findings of choroidal neovascularisations 
(CNV) in assessing the status of exudative age-related 
macular degeneration (eAMD) and to develop a potential 
model to predict the CNV activity.
Methods Retrospective review of the multimodal 
imaging records of patients with eAMD obtained during 
treatment for type 1 or type 2 CNV. The qualitative 
analysis of CNVs on OCT angiograms assessed the 
presence or absence of tiny branching vessels, loops, 
peripheral anastomotic arcades and choriocapillaris 
hypointense halo. These findings were then correlated 
with those of structural OCT scans. A score forecast was 
built and validated.
results One hundred and twenty-six eAMD eyes 
were enrolled in the study. Exudation was observed 
in 90 eyes (71%) on structural OCT. The qualitative 
OCT-A analysis revealed: tiny branching vessels in 
82.5% of the cases, vascular loops in 81.7%, peripheral 
anastomotic arcades in 66.7% and choriocapillaris 
hypointense halo in 54.8%. In the univariate analysis, 
each OCT-A parameter showed a statistically significant 
correlation with exudation on structural OCT (p<0.001). 
The overall analysis demonstrated a sensitivity of 
96.7% and a positive predictive value of 87.9%. In 
the multivariate analysis, a model with four criteria 
predicted an exudative lesion in 97.6% of cases and one 
with two criteria (tiny branching vessels and peripheral 
anastomotic arcades) in 71.2%.
Conclusions The presence of tiny branching vessels and 
a peripheral anastomotic arcade appears to predict the 
lesion activity with a good accuracy and the model based 
on four criteria enables optimal decisions regarding 
retreatment in eAMD.
InTroduCTIon
Age-related macular degeneration (AMD) is one 
of the leading causes of visual impairment in older 
adults in industrialised countries.1 Choroidal 
neovascularisation (CNV) is a characteristic feature 
of exudative AMD (eAMD) and is characterised 
by the growth of abnormal blood vessels from the 
choroid through the Bruch’s membrane.2
Fluorescein angiography (FA) is currently the 
gold standard imaging modality for diagnosing and 
classifying CNVs whereas indocyanine green angi-
ography (ICGA) is used to identify the entire extent 
of the lesion.3 However, small retinal vessels and 
prominent vessels are often concealed by late-phase 
hyperfluorescence and this may compromise the 
precise assessment of vascular features. In addition, 
these techniques use intravenous dyes that can result 
in systemic side effects including anaphylaxis.4
Despite these limitations, FA is routinely used 
in conjunction with structural optical coherence 
tomography (OCT) for the diagnosis and follow-up 
of patients suffering from AMD. OCT findings are 
surrogate markers of leakage and are commonly 
used as treatment or retreatment parameters when 
evaluating the efficacy of anti-vascular endothelial 
growth factor (VEGF) agents in clinical settings as 
well as in current clinical trials.5
OCT angiography (OCT-A) provides a clear, 
depth-resolved visualisation of the retinal and 
choroidal microvasculature.6 7 Swept-source OCT-A 
allows an improved visualisation of the choroid, 
resulting in detailed visualisation of the CNV espe-
cially the sub-retinal pigmented epithelium (RPE) 
component of the neovascularisation.8 9
Previous reports have suggested that OCT-A 
detects CNVs with the same sensitivity as FA.10 11 
Moreover, the correspondences between different 
CNV patterns and the status of neovascular lesions 
have also been evaluated. However, to the best of 
our knowledge, no previous studies have addressed 
the decision efficacy of treating eAMD based solely 
on OCT-A findings.
The aim of this study was to evaluate the predic-
tive role of different OCT-A qualitative findings 
in assessing the status of CNVs and to develop a 
potential predictive scheme based on these morpho-
logical features.
MATerIAls And MeThods
Retrospective cross-sectional review of the medical 
records of consecutive patients observed at the 
Centre Ophtalmologique de l’Odeon between 
January 2017 and April 2017. This study was 
conducted in accordance with the tenets of the 
Declaration of Helsinki and French legislation.
study population
Eligible patients had to meet the following param-
eters: (1) diagnosis of eAMD through multimodal 
imaging (FA, ICGA and structural OCT); (2) type 
1 or type 2 CNV12; and (3) at least one intravitreal 
anti-VEGF injection (IVI) within the last 3 months 
and a minimum interval of 1 month between the 
last IVI and the OCT-A examination. Patients with 
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Figure 1 Multimodal imaging of a 75-year-old patient suffering 
from neovascular age-related macular degeneration and followed up 
for 15 months. The visual acuity after nine anti-vascular endothelial 
growth factor (VEGF) intravitreal injections was 32 ETDRS letters. 
Colour fundus photo (top left) shows the area examined on optical 
coherence tomography (OCT) angiography (green square). The ‘en-face’ 
OCT angiogram (top right), segmented at the level of the pigmented 
epithelium detachment, shows type 1 choroidal neovascularisation 
(CNV) with a well-visible peripheral anastomotic arcade. There is no 
space between all inner branching capillaries. This CNV shows some 
features that are generally associated with an active (exudative) lesion 
such as tiny branching vessels and peripheral arcade. The cross-sectional 
OCT of the same eye does not show any sign of fluid accumulation 
(bottom).
CNV fibrotic scarring, type 3 CNV, polypoidal choroidal vascu-
lopathy, retinal vascular or inflammatory diseases complicated 
with CNV or poor-quality images on OCT-A (signal strength 
index lower than 80) were excluded.
The retreatment protocol was ‘pro-re-nata’ and it was based 
on structural OCT findings. All patients have received a loading 
dose of three monthly injections of anti-VEGF and then followed 
up monthly; an IVI was given only in case of evidence of exuda-
tion on structural OCT scans.13
Image analysis acquisition
A macular volume scan (49 B-scans within a 30°×20° area) 
centred on the fovea was acquired with a spectral domain 
OCT (Spectralis OCT2, Heidelberg Engineering, Heidelberg, 
Germany).14 OCT-A was obtained with a swept-source OCT 
device (Triton SS-OCT, Topcon, Tokyo, Japan) on a scanning 
area of 4.5×4.5 mm and an automatically segmented slab of 
30 µm (shaped on RPE profile) was set immediately above the 
RPE and then moved towards the Bruch’s membrane in order 
to detect flow signals due to CNVs.11 A manual correction of 
the segmented boundaries was performed in a limited number 
of acquired OCT angiograms (less than 5%), especially in case 
of severe outer retinal/RPE disruption. This process was done 
by a senior retina specialist (FC), before the OCT-A qualitative 
grading, in case of incorrect RPE automatic delineation and was 
performed on structural, cross-sectional OCT scans.
data sources
All the patients underwent a comprehensive eye examination 
including best corrected visual acuity (BCVA) using the ETDRS 
visual chart, retinal photography of the fundus, structural OCT 
and OCT-A. The patients’ baseline characteristics included age, 
gender, follow-up duration and number of previous IVI of anti-
VEGF agents.
Variables
Structural OCT findings were used to guide the decision to 
retreat. Two different parameters were assessed: presence of 
subretinal, intraretinal or sub-RPE fluid (vs absence) and central 
macular thickness (CMT, expressed in microns). An exudative 
lesion was defined by the presence of subretinal and/or intra-
retinal (or sub-RPE) fluid and macular thickening on structural 
OCT.14 15
The evaluation of OCT angiograms was performed in order 
to delineate the morphological qualitative features of a CNV. 
We considered four OCT-A criteria11 to qualitatively describe a 
neovascular lesion: (1) presence of tiny branching vessels (thin, 
tangled capillaries) versus mature vessels (defined as volumi-
nous linear filamentous capillaries); (2) presence of an anasto-
motic arcade (peripheral connection between tiny branching 
vessels); (3) presence of loops (inner anastomoses between tiny 
vessels); and (4) presence of perilesional hypointense halo (the 
hypointense area is considered as a region of choriocapillaris 
alteration, corresponding to local flow impairment). Criteria 
were graded in a binary method (1 for presence and 0 for 
absence).
All structural OCT and OCT-A images were separately evalu-
ated 1 month apart from each other by two masked experienced 
ophthalmologists (FC and CF). Their evaluation aimed to accu-
rately determine the morphological features of a CNV on OCT 
angiograms and the presence of exudation on structural OCT 
(figures 1 and 2). This process was useful in evaluating the inter-
grader reproducibility. All images were analysed independently 
in a separate sitting to evaluate intragrader reproducibility. The 
same evaluation was then carried out by a third observer (RS), 
from a different ophthalmological centre, on a validation sample 
from a different group of patients but with the same inclusion 
and exclusion criteria.
statistical analysis
Descriptive statistics (mean±SD or frequencies and percentages) 
were used to analyse all variables. For qualitative variables, intra-
grader and intergrader kappa coefficients were accessed by using 
the χ2 test on a contingency table. Agreement between masked 
observers was assessed using the kappa statistic. A learning 
sample was used to develop a model that describes the relation 
between the qualitative variables and the variable answer and a 
validation sample to test the developed statistical model with 
another observer and different patients. The outcome assess-
ment consisted of the decision to retreat with IVI after structural 
OCT evaluation.
The statistical analysis included an investigation of associa-
tion between the variable of interest and the potential predictors 
(univariate analysis). Principal component analysis with logistic 
regression analysis was performed to predict the effect of the 
four variables on a binary response variable. A set of p uncor-
related factors and normalised coefficients was built with values 
of correlation between the explanatory variable (OCT-A criteria) 
and the variable answer (retreatment decision), to minimise the 
bias related to their multicollinearity. The relative risk for each 
OCT-A criterion was calculated. Receiver operating character-
istic (ROC) analysis of the predictive model was issued. A p 
value <0.05 was considered statistically significant. All demo-
graphic, clinical and structural OCT/OCT-A measurements were 
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Figure 2 Multimodal imaging of an 80-year-old patient suffering 
from neovascular age-related macular degeneration and followed 
up for 18 months. The visual acuity after 12 anti-vascular endothelial 
growth factor (VEGF) intravitreal injections was 27 ETDRS letters. 
Colour fundus photo (top left) shows the area examined on optical 
coherence tomography (OCT) angiography (green square). The ‘en-face’ 
OCT angiogram (top right), segmented at the level of the pigmented 
epithelium detachment, shows type 1 choroidal neovascularisation 
(CNV) with a well-visible network of tiny branching vessels and loops. 
There is no space between all inner branching capillaries. This CNV 
shows some features that are generally associated with an active 
(exudative) lesion such as tiny branching vessels. The cross-sectional 
OCT of the same eye shows subretinal fluid accumulation (bottom).
Table 1 Demographic and clinical characteristics of patients during 
anti-VEGF intravitreal injection treatment
Total eyes 126
Patients, n (%) 126
  Female 97 (77)
  Male 29 (33)
Age, mean±SD (years) 79.5 (8.9)
Mean BCVA, mean±SD (ETDRS letters) 63.7 (14.8)
Follow-up time, mean±SD (months) 22.9 (13.5)
Previous anti-VEGF treatment, mean±SD, n 10.4 (6.5)
IVI interval, mean±SD (months) 2.35 (1.42)
CNV classification, n (%)
  Type 1 107 (85)
  Type 2 21 (15)
BCVA, Best Corrected Visual Acuity; CNV, choroidal neovascularisation; IVI, 
intravitreal injection; VEGF, vascular endothelial growth factor.
Table 2 Sensitivity and specificity of each optical coherence 
tomography angiography feature of choroidal neovascularisation
Tiny branching Arcade loops halo
Sensitivity (%) 94.4 78.9 79.6 62.8
Specificity (%) 47.2 63.9 91.3 64.9
PPV (%) 81.7 84.5 97.6 76.2
NPV (%) 77.3 54.8 50 88.1
FP rate 0.53 0.36 0.09 0.07
FN rate 0.06 0.21 0.20 0.35
FN, false negative; FP, false positive; NPV, Negative Predictive Value; PPV, Positive 
Predictive Value.
tabulated in Microsoft Excel 2013 software from Microsoft. All 
statistics were performed through XLSAT 2017 (Data Analysis 
and Statistical Solution for Microsoft Excel, V.2017.3).
resulTs
One-hundred and twenty-six eyes of 126 consecutive patients 
with exudative eAMD were enrolled in the current study. All 
subjects were Caucasian (97 females, 77%) with a mean age of 
79.5±8.9 years. Baseline demographical and clinical characteris-
tics are summarised in table 1.
Fluid was identified in 101 eyes (80%). Mean CMT was 
319.6±112.5 µm.
The decision to treat and mean CMT were positively correlated 
in a statistically significant manner (p<0.002).
In OCT-A image analysis, the occurrence of the four different 
parameters was distributed as follows: tiny branching vessels in 
82.5% (104 eyes), vascular loops in 81.7% (103 eyes), a periph-
eral anastomotic arcade in 66.7% (84 eyes) and a hypointense 
choriocapillaris halo in 54.8% (69 eyes). The intragrader kappa 
coefficient was 88.5% and the intergrader kappa coefficient was 
78%. The concordance rate on the validation test from the third 
grader (RS) on 104 similar records of retreated CNV was 90.9%.
In the univariate analysis, there was a weak association 
between IVI number and the presence of a peripheral arcade 
(r=0.171, p=0.04) and an absence of an association between 
IVI number and tiny branching vessels (p=0.071), vascular loops 
(p=0.22) or a hypointense choriocapillaris halo (p=0.064). All 
the four different OCT-A criteria showed a statistically signifi-
cant (p<0.0001) correlation with an active lesion on structural 
OCT. Sensitivity, specificity and positive and negative predic-
tive values were independently assessed for each qualitative 
parameter. False positive and false negative rates were also inde-
pendently assessed for all qualitative parameters (table 2).
In the overall analysis, considering all four OCT-A criteria, 
sensitivity was 96.7% and specificity was 66.7%. The false 
positive and negative rates were 33.3% and 3.3%, respectively. 
Considering the 71.4% prevalence of eAMD in our study, the 
positive predictive value was 87.9%, and the negative predictive 
value was 88.9%.
On multivariate analysis, the combination of all the four 
OCT-A criteria predicted the exudative status of the CNV lesion 
in 97.6% of cases. The ROC curve of a model including the four 
initial variables (OCT-A criteria) predicts the status of the lesion 
in 94.4% (figure 3). The cluster of tiny branching network and 
the peripheral arcade on OCT-A predicted a positive outcome 
(exudative status of the CNV) for two OCT-A criteria (tiny 
branching and peripheral arcade) in 71.23% of cases.
The principal component analysis demonstrated the strength 
of the link between the explanatory variable (OCT-A criteria) 
and the variable answer (exudative status of the CNV and the 
consequential decision of treatment) for peripheral arcade, 
loops, tiny branching vessels and hypointense halo with a rela-
tive risk of 2.41, 2.96, 6.76 and 1.73, respectively (table 3).
dIsCussIon
In the current study, we tried to validate new criteria for treating 
patients with eAMD based on OCT-A-based CNV qualitative 
findings and compared these with the well-established structural 
OCT outcomes. This morphological CNV assessment was previ-
ously reported by Coscas et al in a pilot study of 73 consecutive 
patients with AMD.11
 o
n
 4 January 2019 by guest. Protected by copyright.
http://bjo.bmj.com/
Br J O
phthalm
ol: first published as 10.1136/bjophthalmol-2018-313065 on 22 November 2018. Downloaded from 
4 Coscas F, et al. Br J Ophthalmol 2018;0:1–5. doi:10.1136/bjophthalmol-2018-313065
Clinical science
Figure 3 The receiver operating characteristic (ROC) curve between 
sensitivity and specificity showed that the current model, based on 
optical coherence tomography angiography findings, correctly predicts 
the active status of a choroidal neovascularisation (AUC, area under the 
curve) with a high probability for a therapeutic decision in each patient.
Table 3 Normalised coefficients of CNV features with principal 
component analysis
CnV features Values lower bound (95%) upper bound (95%) P values
Arcade 0.575 0.254 0.896 0.000
Loops 1.322 0.517 2.127 0.001
Tiny branching 1.207 0.627 1.788 <0.0001
Halo 0.078 −0.717 0.873 0.848
CnV features rr lower bound (95%) upper bound (95%)
Arcade 2.41 1.68 3.46
Loops 2.93 1.62 5.31
Tiny branching 6.76 2.58 17.75
Halo 1.73 1.37 2.17
Values of the explanatory variables of the statistical mode.
Value: strength of the link between the explanatory variable (criteria) and the 
variable answer (decision of retreatment).
CNV, choroidal neovascularisation; RR, relative risk.
The probability of IVI treatment based on the presence of all 
four OCT-A criteria on OCT-A was 97.6%. The criterion ‘tiny 
branching vessels’ had the best correlation value with treatment 
decision and the highest relative risk. The criterion ‘halo’ had a 
non-statistically significant link with the decision of treatment 
and a low relative risk. In clinical activity, it is common prac-
tice to cluster criteria in pairs to easily summarise morphological 
changes. According to our analysis, tiny branching vessels and 
the peripheral arcade are the OCT-A criteria with the highest 
relative risk of exudative signs on structural OCT. Using a model 
with normalised coefficients, we demonstrated that the proba-
bility of IVI treatment considering tiny branching vessels and the 
peripheral arcade on OCT-A is 71.23%, which is inferior to a 
model containing the four criteria.
These two criteria were also suggested as important biomarkers 
by Al-Sheikh et al16 in a study of 31 eyes including 11 eyes with 
active lesions and 20 eyes with quiescent lesions. Tiny branching 
vessels were present in 82% of active lesions but in only 30% 
of quiescent ones (p<0.05). The peripheral arcade was also 
present in 82% of the active lesions compared with only 40% 
of the quiescent ones. This huge difference was not statistically 
significant probably due to the small sample size and consequent 
lack of adequate power. Nevertheless, these criteria may be 
considered as potential biomarkers of CNV activity.
The biological basis of these criteria could be related to the 
angiogenetic process. The prominent vessel is covered by peri-
cytes and appears to be resistant to anti-VEGF therapy whereas 
the tiny branching capillaries, sprouting from the periphery 
of the CNV, are more vulnerable due to the lack of pericytes. 
Moreover, since the appearance of pericytes on vessel walls is a 
later process than the angiogenetic one, it can be associated with 
new-onset, immature capillaries, therefore potentially linked 
with the exudative status of a neovascular lesion.17 18
We showed a high rate (12/36; 33.3%) of false positive qualita-
tive evaluations on OCT-A (ie, potentially active CNV according 
to the presence of OCT-A criteria but inactive according to the 
OCT B-scan). When assessing the entire patient sample (false 
positive+false negative ones) this rate dropped to 9.52%. This 
ratio could be explained with a potential superiority of OCT-A 
criteria, compared with structural OCT, in enabling the earlier 
detection of CNV activity, before the exudation occurs. The aim 
of early detection is to enable a prompt treatment in order to 
preserve the macular architecture and, consequently, the visual 
acuity. Several studies on eAMD showed that a decreased visual 
acuity is a late sign of activity and, currently, we mostly treat 
patients according to structural OCT signs, rather than BCVA, 
according to the principle: the sooner is the fluid detection, the 
better is the final visual acuity.19
Every imaging modality suffers from some limitations. We 
observed some false negative patients on OCT-A. These cases 
corresponded mainly to patients with pigment epithelium 
detachment (PED) or haemorrhage with potential difficulties in 
imaging the CNV due to attenuation or blockage of the signal.
Several previous studies, using different devices and different 
decorrelation algorithms (spectral domain or swept-source 
OCT), reported that the sensitivity of OCT-A in detecting 
choroidal neovascular lesions ranged from 50% to 87%.7 9 20 In 
a recent prospective study of 182 eyes, Eandi et al demonstrated 
a good agreement (r=0.84) between ICGA and OCT-A for CNV 
size, with a higher percentage of well-defined lesion borders 
detected by OCT-A.21 However, the agreement between these 
techniques was only moderate for the definition of CNV borders 
(kappa=0.4).21 We used two masked experienced readers and 
a validation test to minimise any resulting bias: as a result the 
intergrader correlation coefficient was very good.
The study patient population includes only patients who were 
previously treated with anti-VEGF agents. However, according 
to previous studies, there is only subtle change after anti-VEGF 
treatment and, in case of recurrence, the CNV lesion regains its 
original morphology.17 20 22 23 Large prominent vessels in fact are 
not affected by anti-VEGF treatment whereas the tiny vessels are 
attenuated and pruned.
Potential limitations of the current study are its retrospec-
tive nature and the relatively high prevalence of patients with 
an active lesion in which OCT-A criteria were tested. We 
acknowledge that treatment-naïve eyes or quiescent lesions 
were not enrolled. Further studies including a larger proportion 
of treatment-naïve and quiescent CNVs might be performed 
in order to validate the negative predictive value of our study 
criteria. Moreover, current results are based on qualitative 
criteria assessed by OCT-A while quantitative methods could 
be more reliable. The qualitative OCT-A analysis has its own 
limitations characteristic of all binary qualitative systems; for 
example, even if two networks have the same qualitative eval-
uation, they may have different degrees of activity that might 
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impact the treatment decision and follow-up. Therefore, quan-
tification of the extent of neovascular networks is a task of 
major importance,15 although quantitative representations of 
neovascular networks are often subjective and rely on manual 
delineation.20 24 Proven methods for automated detection and 
quantification of CNV are lacking, mostly due to projection and 
foreground imaging artefacts.25 Future research may shed some 
light on the quantification of the size, density and complexity of 
neovascular networks and their correlation with the decision to 
treat and response to treatment.
In conclusion, OCT-A appears to be a useful technique in 
guiding the decision to treat and following up patients with 
eAMD, and that could be routinely used in clinical practice. A 
qualitative assessment of the CNV, based on OCT-A criteria, may 
substantially increase the capability to detect early recurrences, 
leading to a proactive therapeutic strategy, and providing the 
clinician additional parameters to establish treatment decisions 
and monitoring in eAMD.
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